Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Financial Officer

Exec. VP and COO

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and hematologic malignancies, such as KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. It primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-12-19	Premium	bought	Premium	Premium	Premium	-
2023-11-10	Premium	bought	Premium	Premium	Premium	-
2022-11-25	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-09-19	Premium	bought	Premium	Premium	Premium	-
2022-09-16	Premium	bought	Premium	Premium	Premium	-
2022-09-16	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-09-15	Premium	bought	Premium	Premium	Premium	-
2022-09-15	Premium	bought	Premium	Premium	Premium	-
2022-07-05	Premium	acquired	Premium	Premium	Premium	-
2021-09-21	Premium	bought	Premium	Premium	Premium	-
2021-09-10	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-03-26	Premium	bought	Premium	Premium	Premium	-
2021-03-23	Premium	bought	Premium	Premium	Premium	-
2021-03-23	Premium	bought	Premium	Premium	Premium	-
2021-03-23	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-03-23	Premium	bought	Premium	Premium	Premium	Exec. VP and COO
2021-03-22	Premium	bought	Premium	Premium	Premium	-
2021-03-19	Premium	bought	Premium	Premium	Premium	-
2021-03-18	Premium	bought	Premium	Premium	Premium	-
2021-03-04	Premium	bought	Premium	Premium	Premium	-
2021-01-02	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2021-01-02	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2021-01-02	Premium	sold (taxes)	Premium	Premium	Premium	Exec. VP and COO
2021-01-02	Premium	acquired	Premium	Premium	Premium	Exec. VP and COO
2020-11-23	Premium	sold	Premium	Premium	Premium	Exec. VP and COO

CRDF - Cardiff Oncology, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for CRDF